VBLT

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VBLT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/11	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/05/11	06 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/05/11	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/05/11	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/05/11	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/05/11	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/05/07	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/04/20	05 : 56	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/04/12	21 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/04/12	06 : 00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/04/10	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/04/09	01 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/04/02	05 : 30	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/03/25	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/02/22	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/02/22	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/02/16	23 : 00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/02/06	07 : 00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/02/03	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/27	01 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/27	01 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/27	01 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/27	01 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/27	01 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/12	07 : 22	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/09	06 : 21	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/04	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2024/01/03	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2023/12/29	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd
2023/12/27	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VBLT	Vascular Biogenics Ltd